A novel isoform of ATOH8 promotes the metastasis of breast cancer by regulating RhoC. (13th October 2020)

• Record Type: Journal Article
• Authors: Xu, Mengyao; Huang, Shan; Dong, Xiaoli; Chen, Yanan; Li, Miao; Shi, Wen; Wang, Guanwen; Huang, Chongbiao; Wang, Qiong; Liu, Yanhua; Sun, Peiqing; Yang, Shuang; Xiang, Rong; Chang, Antao
• Editors: Lu, Hua
• Is Part Of: Journal of molecular cell biology. Volume 13:Number 1(2021)
• Page Start: 59
• Page End: 71
• Publication Date: 2020-10-13
• Subjects: breast cancer -- ATOH8 -- metastasis -- RhoC; Molecular biology -- Periodicals; 571.605
• DOI: 10.1093/jmcb/mjaa050
• Languages: English
• ISSNs: 1674-2788

Abstract

Abstract: Metastases are the main cause of cancer-related mortality in breast cancer. Although significant progress has been made in the field of tumor metastasis, the exact molecular mechanisms involved in tumor metastasis are still unclear. Here, we report that ATOH8-V1, a novel isoform of ATOH8, is highly expressed in breast cancer and is a negative prognostic indicator of survival for patients. Forced expression of ATOH8-V1 dramatically enhances, while silencing of ATOH8-V1 decreases the metastasis of breast cancer cell lines. Moreover, ATOH8-V1 directly binds to the RhoC promoter and stimulates the expression of RhoC, which in turn enhances the metastasis of breast cancer. Altogether, our data demonstrate that ATOH8-V1 is a novel pro-metastatic factor that enhances cancer metastasis, suggesting that ATOH8-V1 is a potential therapeutic target for treatment of metastatic cancers.